Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z6OW
|
|||
| Former ID |
DNCL003280
|
|||
| Drug Name |
Staphylococcus aureus vaccine
|
|||
| Indication | Bacterial infection [ICD-11: 1A00-1C4Z; ICD-10: A00-B99] | Phase 2/3 | [1] | |
| Staphylococcus infection [ICD-11: 1B5Y; ICD-10: A49.0; ICD-9: 001-139] | Phase 1 | [2], [3] | ||
| Company |
Novartis Vaccines & Diagnostics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. Front Cell Infect Microbiol. 2012 Feb 22;2:16. | |||
| REF 2 | ClinicalTrials.gov (NCT01160172) A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults. U.S. National Institutes of Health. | |||
| REF 3 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035177) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.